Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model-Reference-Cited by-同舟云学术

Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model

Published:2011-10 Issue: Volume:194 Page:250-261
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Carta A.R.,Frau L.,Pisanu A.,Wardas J.,Spiga S.,Carboni E.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference78 articles.

1. Brain microglia constitutively express beta-2 integrins;Akiyama;J Neuroimmunol,1990

2. Quantification of PPAR-gamma protein in monocyte/macrophages from healthy smokers and non-smokers: a possible direct effect of nicotine;Amoruso;Life Sci,2007

3. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen;Bernardo;J Neurochem,2005

4. Regulation of glial cell functions by PPAR-gamma natural and synthetic agonists;Bernardo;PPAR Res,2008

5. Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients;Blum-Degen;Neurosci Lett,1995

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Function and Mechanism of Abscisic Acid on Microglia-Induced Neuroinflammation in Parkinson’s Disease;International Journal of Molecular Sciences;2024-04-30

2. The Contribution of Type 2 Diabetes to Parkinson’s Disease Aetiology;International Journal of Molecular Sciences;2024-04-15

3. Uncovering Novel Therapeutic Targets for Parkinson’s Disease;ACS Chemical Neuroscience;2023-05-25

4. Design and Development of Novel Glitazones for Activation of PGC-1α Signaling Via PPAR-γ Agonism: A Promising Therapeutic Approach against Parkinson’s Disease;ACS Omega;2023-02-10

5. PPARs and Their Neuroprotective Effects in Parkinson’s Disease: A Novel Therapeutic Approach in α-Synucleinopathy?;International Journal of Molecular Sciences;2023-02-07